NEVRO CORP.
NVRO
NVRO was delisted on the 2nd of April, 2025.
153 hedge funds and large institutions have $539M invested in NEVRO CORP. in 2024 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 48 increasing their positions, 54 reducing their positions, and 20 closing their positions.
70% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 20
9% more funds holding
Funds holding: 140 → 153 (+13)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
11% less repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 54
35% less capital invested
Capital invested by funds: $834M → $539M (-$296M)
91% less call options, than puts
Call options by funds: $1.26M | Put options by funds: $14.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$13.1M |
| 2 |
AC
Armistice Capital
New York
|
+$7.41M |
| 3 |
EP
Eversept Partners
New York
|
+$6.44M |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
+$5.66M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$5.03M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$17.9M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$14.8M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$14.7M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$9.96M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$8.5M |
NVRO Hedge Fund Activity: Q1 2024 in Review
153 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q1 2024, worth a combined $539M — down 35% from $834M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new NVRO positions and 20 closed out — a net gain of 14 holders — while 48 added to existing stakes and 54 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $13.1M. The largest seller was Fidelity Investments, cutting an estimated $17.9M.
- 153 institutional investors held NEVRO CORP. (NVRO) as of Q1 2024, up from 140 in Q4 2023.
- Funds reported $539M of NEVRO CORP. stock for Q1 2024, down 35% quarter-over-quarter.
- 34 funds opened new NEVRO CORP. positions in Q1 2024 and 20 closed out, a net change of +14 holders.
- The largest NEVRO CORP. buyer in Q1 2024 was Citadel Advisors, an estimated $13.1M added.
- The largest NEVRO CORP. seller in Q1 2024 was Fidelity Investments, an estimated $17.9M sold.
Based on aggregated 13F filings for Q1 2024.